Abstract
Malignant Mesothelioma: Asbestos are naturally occurring fibrous silicate materials. It is well recognised that inhalation of asbestos fibres especially amphiboles is the most important risk factor for developing mesothelioma. The epidemiological models of association between the risks of asbestos and malignant mesothelioma take into consideration not only cumulative exposure but also time since first exposure. Current epidemiological estimates suggest that mesothelioma will remain a public health problem for a number of years with epidemiological studies suggesting that the peak incidence of mesothelioma has not been reached. In the global context, mesothelioma remains responsible for between 15,000 - 20,000 deaths annually. Malignant mesothelioma can be divided as per World Health Organization classification into epithelioid, sarcomatoid, desmoplastic and biphasic subtypes.
Keywords: Asbestos, epidemiology, malignant mesothelioma, pathology.
Graphical Abstract
Current Respiratory Medicine Reviews
Title:Epidemiology and Pathology of Malignant Mesothelioma
Volume: 12 Issue: 4
Author(s): Jack A. Kastelik, Mahmoud Loubani, Michael Greenstone, Simon Hart and Anne Campbell
Affiliation:
Keywords: Asbestos, epidemiology, malignant mesothelioma, pathology.
Abstract: Malignant Mesothelioma: Asbestos are naturally occurring fibrous silicate materials. It is well recognised that inhalation of asbestos fibres especially amphiboles is the most important risk factor for developing mesothelioma. The epidemiological models of association between the risks of asbestos and malignant mesothelioma take into consideration not only cumulative exposure but also time since first exposure. Current epidemiological estimates suggest that mesothelioma will remain a public health problem for a number of years with epidemiological studies suggesting that the peak incidence of mesothelioma has not been reached. In the global context, mesothelioma remains responsible for between 15,000 - 20,000 deaths annually. Malignant mesothelioma can be divided as per World Health Organization classification into epithelioid, sarcomatoid, desmoplastic and biphasic subtypes.
Export Options
About this article
Cite this article as:
Kastelik A. Jack, Loubani Mahmoud, Greenstone Michael, Hart Simon and Campbell Anne, Epidemiology and Pathology of Malignant Mesothelioma, Current Respiratory Medicine Reviews 2016; 12 (4) . https://dx.doi.org/10.2174/1573398X12666160817145726
DOI https://dx.doi.org/10.2174/1573398X12666160817145726 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design Physico-Chemical Properties Mediating Reproductive and Developmental Toxicity of Engineered Nanomaterials
Current Medicinal Chemistry Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors
Current Medicinal Chemistry Mesenchymal Stem Cells Promote Caspase Expression in Molt-4 Leukemia Cells <i>Via</i> GSK-3α/Β and ERK1/2 Signaling Pathways as a Therapeutic Strategy
Current Gene Therapy Cancer Stem Cells Switch on Tumor Neovascularization
Current Molecular Medicine Focal Adhesion Kinase: From In Vitro Studies to Functional Analyses In Vivo
Current Protein & Peptide Science Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB
Current Neurovascular Research Preface: MicroRNA as Disease Biomarkers
MicroRNA MDA-7/IL-24-Based Cancer Gene Therapy: Translation from the Laboratory to the Clinic
Current Gene Therapy Points of Therapeutic Intervention Along the Wnt Signaling Pathway in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Immune Cell-derived Vesicles: Modulators and Mediators of Inflammation
Current Pharmaceutical Design Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus
Current Cancer Drug Targets Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging
Anti-Cancer Agents in Medicinal Chemistry The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Proteomics Targeted – Therapy and Imaging Response: A New Paradigm For Clinical Evaluation?
Reviews on Recent Clinical Trials The Biological Role of mTOR in the Pathogenesis of Solid Tumors: An Overview
Current Enzyme Inhibition Current Developments on Synthesis, Redox Reactions and Biochemical Studies of Selenium Antioxidants
Current Chemical Biology Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence
Current Pharmaceutical Design Structure-Activity Relationship of Supramolecular Compounds in Drug Delivery
Mini-Reviews in Organic Chemistry